The distinct functions of cohesin complexes carrying STAG1 or STAG2 need to be unraveled. 31 STAG2 is commonly mutated in cancer and germline mutations have been identified in 32 cohesinopathy patients. To better understand the underlying pathogenic mechanisms, we here 33 report the consequence of Stag2 ablation in mice. STAG2 is largely dispensable in adults and its 34 tissue-wide inactivation does not lead to tumors but reduces fitness and affects both hematopoiesis 35 and intestinal homeostasis. STAG2 is also dispensable for murine embryonic fibroblasts in vitro. 36 In contrast, null embryos die by mid gestation showing global developmental delay and heart 37 defects. Histopathological analysis and RNA-sequencing unveiled that STAG2 is required both for 38 proliferation and regulation of cardiac transcriptional programs and in its absence, secondary heart 39 field progenitors fail to enter the heart tube. These results provide compelling evidence on cell-and 40 tissue-specific roles of the two cohesin complexes and how their dysfunction contributes to disease. 41 42 Given the growing importance of STAG2 in human disease, we generated a Stag2 conditional knock 91 out (cKO) mouse strain to identify the consequences of eliminating cohesin-STAG2 in cells, 92 embryos and adult tissues. 93 94
Introduction 43 Cohesin is a four-subunit complex that holds the sister chromatids together to ensure faithful DNA 44 repair by homologous recombination and proper chromosome segregation during cell division (1). 45 It is present in all cells and its cohesive function is essential for proliferation. In addition, cohesin 46 contributes to the spatial organization of the genome and to the activation and repression of tissue-47 specific transcriptional programs together with architectural proteins such as CTCF and 48 transcriptional regulators like Mediator (2-4). In the cohesin complexes present in vertebrate 49 somatic cells, the Structural Maintenance of Chromosomes (SMC) heterodimer of SMC1A and 50 SMC3 associates with the kleisin subunit RAD21 and with one of the two versions of the Stromal 51 Antigen (SA/STAG) subunit, STAG1 or STAG2. The two variants are present in all tissues and 52 cell types, but their functional specificity is not well established (5). We previously showed that 53 genetic ablation of Stag1 in mice is embryonic lethal, which indicates that the two complexes are 54 not redundant, at least during embryonic development (6). Lethality starts after day 11.5 of 55 gestation (E11.5) but a small fraction of embryos survive to E18.5 and present a severe 56 developmental delay and general hypoplasia (7) . 57 In Stag1 null mouse embryonic fibroblasts (MEFs) telomere cohesion is impaired, preventing 58 efficient replication of telomeres and causing chromosome segregation defects in mitosis (6). 59 Centromere and arm cohesion are not clearly affected, which suggests that cohesin-STAG1 is 60 specifically required for telomere cohesion whereas cohesin-STAG2 contributes to cohesion in 61 other chromosomal regions. Results in human cells are in line with these findings, although the 62 extent of cohesion defects reported in the absence of STAG2 is variable. In any case, a single 63 variant is sufficient to maintain cell viability in culture (6, 8, 9) . 64 Cohesin variants also contribute distinctly to genome organization and gene regulation. In Stag1 65 null MEFs cohesin distribution is altered and so is their transcriptome (7) . In the pancreas of 66 heterozygous Stag1 mice, the architecture of the Reg locus and the transcription of some of its 67 genes are also changed compared to pancreas from wild type littermates, suggesting that STAG2 68 is not sufficient to compensate for the reduced levels of STAG1 (10). In human mammary 69 epithelial cells, downregulation of STAG1 or STAG2 result in distinct changes in gene expression 70 and chromatin contacts (5). Cohesin-STAG1 and cohesin-STAG2 colocalize with CTCF and play 71 a major role in preservation of topologically associating domain (TAD) borders. By contrast, 72 cohesin-STAG2 is also present at enhancers lacking CTCF that are bound by other transcriptional 73 regulators (3, 5, 11) . Importantly, cohesin-STAG1 cannot occupy these non-CTCF cohesin-sites 74 even when STAG2 is absent (5). In mouse embryonic stem cells, cohesin-STAG2 promotes 75 compaction of Polycomb domains and the establishment of long-range interaction networks 76 between distant Polycomb-bound promoters that are important for gene repression (11). 77 Germline mutations in genes encoding cohesin and its regulatory factors are at the origin of a group 78 of human syndromes collectively known as cohesinopathies. Cornelia de Lange syndrome (CdLS) 79 is the most common of them and up to 60% of the patients carry heterozygous mutations in NIPBL, 80 a protein involved in loading cohesin on chromatin (12). Clinical features often include growth 81 retardation, intellectual disability, facial dysmorphism and congenital heart defects. Recently, 82 germline mutations in STAG1 and STAG2 have been identified in patients with features partially 83 overlapping those of CdLS and other cohesinopathies (13-17). Somatic mutations in cohesin 84 genes, particularly in STAG2, have also been identified in several tumor types (18). STAG2 has 85 been recognized as one of the twelve genes significantly mutated in four or more cancer types (19). 86 Among them, STAG2 loss is most frequent in urothelial bladder cancer (20). The evidence 87 emerging from the study of diseases associated with both germline and somatic cohesin mutations 88 strongly suggests that gene deregulation, rather than defects in chromosome segregation, underlies 89 the pathogenic mechanism (12, 20, 21). 90 
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To generate a cKO allele of the X-linked Stag2 gene, we used a targeting construct that carries loxP 97 sites flanking exon 7 along with an FRT-flanked cassette encompassing a neomycin resistance 98 selection gene, a splicing acceptor site and a polyadenylation sequence ( Fig. S1A ). Correctly 99 targeted embryonic stem (ES) cells were screened by Southern blotting and were infected with 100 adeno-FLP to eliminate this cassette before microinjection in C57BL/6J blastocysts ( Fig. S1B ). 101 Germline transmission of the Stag2 lox allele was assessed by PCR ( Fig. S1C ). Next, Stag2 lox/lox 102 females were crossed with males carrying hUBC-CreERT2 for ubiquitous, tamoxifen-induced 103 activation of the Cre recombinase. Embryos were extracted at embryonic stage E12.5 to generate 104 cKO MEFs. Upon addition of 4-hydroxy-tamoxifen (4-OHT) to the culture medium for 4 days, 105 STAG2 protein levels in treated MEFs (KO) dropped below 5% of the amount present in untreated 106 MEFs (WT) and compensatory upregulation of STAG1 could be observed (Fig. 1A) . The doubling 107 time of STAG2 deficient cells was higher ( Fig. 1B ), but flow cytometry analysis did not reveal 108 differences in the cell cycle profiles of WT and KO MEFs (Fig. 1C ). We next examined cohesion 109 and chromosome segregation. For these experiments, Stag2 was deleted in serum-starved 110 conditions and cells going through the first mitosis after release from the G0 arrest were collected. 111 We detected very few cases of complete sister chromatid unpairing in metaphase spreads in WT or 112 KO MEFs (1.3% and 3% of chromosomes examined, respectively; dark green square in Fig. 1D ). 113 However, we did observe a larger fraction of chromosomes per metaphase in which centromere 114 cohesion was loosened, as evidenced by increased distance between sister centromeres (26% in KO 115 vs 11% in WT MEFs; light green square in Fig. 1D ). We also found a ca. 2-fold increase in the 116 percentage of anaphase cells with lagging chromosomes and/or chromosome bridges among KO 117 MEFs compared with WT MEFs (29% vs 17%), although the difference did not reach statistical 118 significance ( Fig. 1E ). Finally, we observed that the proportion of metaphases with a normal 119 chromosome number (n=40) decreased more the longer MEFs were grown in the absence of 120 STAG2 ( Fig. 1F ). Overall, these defects are milder than those identified in Stag1 null MEFs (6) or 121 in C2C12 myoblasts or HeLa cells after STAG2 downregulation by siRNA (6, 22) . We conclude 122 that primary cultured cells almost completely lacking cohesin-STAG2 can proliferate, although at 123 slower rates, and maintain sufficient cohesion to divide successfully but lose chromosomes more 124 frequently that wild type cells. To determine whether STAG2 is essential in adulthood, 4-week old Stag2 cKO mice carrying or 128 not the hUBC-CreERT2 transgene (KO and WT hereafter) were fed continuously with a tamoxifen-129 containing diet (TMX). We did not observe an acute loss of viability in the KO mice, but their 130 survival was significantly shorter than that of WT mice ( Fig. 2A ). There were no preneoplastic or To determine whether STAG2 is essential for embryonic development, we crossed Stag2 lox/lox 178 females with males carrying the CAG-Cre transgene, coding for a Cre recombinase that is expressed 179 ubiquitously from the zygote stage. Since Stag2 is an X-linked gene, male embryos resulting from 180 this cross would be either wild type (WT) or null (KO) for Stag2 while females would be WT or 181 heterozygous (see genotyping strategy in Fig. S1D ). We thus focused our analyses on the male 182 embryos. None of the KO male embryos extracted at E12.5 was alive, suggesting an earlier 183 embryonic lethality (Fig. 4A ). In litters extracted at earlier stages we found live KO embryos at (or 184 close to) the expected Mendelian ratios at E8.5 and E9.5, but not later ( Fig. 4A ). 185 Immunohistochemical analyses of embryo sections with STAG2-specific antibodies confirmed 186 tissue-wide absence of the protein (a section from the E9.5 embryonic heart is shown as an example 187 in Fig. 4B ). Importantly, E9.5 KO embryos were visibly smaller than their wild type littermates Impaired deployment of progenitors into the heart tube in Stag2 mutant embryos 246 While decreased proliferation might account for the global growth delay observed in the heart (and 247 other organs) in mutant embryos, it failed to explain why morphological defects were more evident 248 in certain heart structures, i.e. the OFT and right ventricle (Fig. 4E) . Interestingly, these structures 249 derive from second heart field (SHF) progenitors, while the left ventricle derives from the first heart 250 field (FHF) (27). More specifically, ISL1+ progenitors present in the ASHF migrate into the heart 251 tube contributing to the OFT and right ventricle (Fig. S5A) . In mutant embryos, the length of inner 252 and outer curves of the OFT was reduced compared to controls, suggesting a problem in the 253 migration of ASHF progenitors (ISL1+) into the OFT (Fig. S7 ). To test this possibility, we 254 quantified total cell numbers in heart sections. In the neural tube, heart chambers and OFT, 255 cellularity of KO embryos was lower than in WT1 and more similar to WT2 embryos, consistent 256 with reduced size and proliferation rates. In contrast, cell numbers in the ASHF were similar in KO 257 and WT1 littermates (Fig. 5C ), despite mutants showing a much reduced proliferation rate (Fig. 258 5B). Moreover, while the fraction of ISL1+ progenitors in ASHF was similar in all embryos, it 259 decreased in the OFT of KO embryos compared to both controls (Fig. 5D ). These findings strongly 260 suggest that STAG2 loss results in accumulation of progenitors in the ASHF that fail to migrate 261 into the heart tube, leading to morphological defects in ASHF derivatives such as the right ventricle 262 and the OFT. Defects in migration of progenitors has been suggested as the cause of heart defects 263 in murine embryos and zebrafish deficient for the cohesin loader NIPBL (28, 29). analysis confirmed the functional specificity of these gene sets ("cardiac" and "neural" genes, for 274 simplicity; Fig. 6A and Table S1 ). STAG2 loss had a greater impact on the heart transcriptome, as 275 shown in the heatmap of Fig. 6A . Accordingly, pairwise comparisons between WT and KO samples 276 for each tissue identified 846 DEGs in heart but only 5 in neural tube (FDR<0.05; Fig. 6B and Table   277 S2). Among the DEGs in heart, there were 222 and 112 genes from the cardiac and neural gene 278 sets, respectively, indicating that tissue-specific genes were preferentially affected by STAG2 loss 279 ( Fig. 6C and Table S1 ). Moreover, most cardiac genes were downregulated in the heart of mutant 280 embryos, whereas the neural genes were upregulated therein (Fig. 6D) . These findings agree with 281 the proposed role of cohesin-STAG2 in tissue-specific transcription, promoting activation of genes 282 specifying a tissue (i.e., cardiac genes in heart) and repression of alternative gene programs (e.g., 283 neural genes in heart) (5). A closer look at the list of DEGs in heart revealed several cardiomyocyte 284 markers and well-established regulators of SHF among the downregulated genes ( Fig. 6B, right) . variants (13-17). Since STAG2 is an X-linked gene, the embryonic lethality of Stag2 null murine 342 embryos reported here explains why inactivating germline mutations will not be tolerated in males 343 while heterozygous females may survive through the selection of cells in which the wild type allele 344 is not silenced by the X inactivation process. The variable penetrance observed in STAG2 deficient 345 mice as well as the contribution of epistatic events thus likely accounts for phenotypic diversity in 346 patients carrying STAG2 mutations. 347 In summary, we here show that cells lacking cohesin-STAG2 are viable both in vitro (tissue culture) 348 and in vivo (in embryos and adult tissues), confirming that cohesin-STAG1 is sufficient to fulfill 349 essential cohesin functions (8, 9) . However, their decreased proliferation and altered transcriptomes 350 lead to embryonic lethality, a result that provides further compelling evidence for cell-and tissue-351 specific roles of the two cohesin complexes and how their dysfunction may contribute to disease. 352 We speculate that genomic changes derived from decreased accuracy of chromosome segregation and phenotypic variability of cohesinopathies. Genet. Med. 21, 663-675 (2019 
